U.S. Surgitech, Inc. Celebrates Patent Award for Innovative SurgyPad Patient Positioner

August 16, 2023 12:05 AM AEST | By EIN Presswire

Google News:

U.S. Surgitech, Inc. Celebrates Patent Award for Innovative SurgyPad Patient Positioner — Image source: EIN Presswire

Recent News

HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER "HBNB"

Multi-Million Dollar Settlements for Victims - Foyle Legal Wins Its Se...

Gerald Group Warns Against Unauthorised Soremi SA Tenders of Copper Ca...

Awards Presentation Ceremony of the "26th DigiCon6 ASIA Awards - Hong...

CAROL STREAM, IL, UNITED STATES, August 15, 2023/EINPresswire.com/ -- U.S. Surgitech, Inc., a leading medical device manufacturer, is pleased to announce that it has been awarded a patent for its revolutionary SurgyPad patient positioning system. This milestone represents a significant achievement for the company and further solidifies its position as a leader in the medical device industry.

"We are thrilled to receive the patent for our SurgyPad product line," said Maaz Meah, CEO of U.S. Surgitech. “This patent award is a testament to the dedication and hard work of our team in setting new standards in surgical care.”

The SurgyPad is a cutting-edge patient positioning system designed to enhance patient safety and comfort during surgical procedures. Its unique design incorporates integrated arm protectors, an anti-skid strip along the back, and added safety straps for impeccable patient security. Its moisture-absorbing, high-rebound foam provides optimal support and pressure distribution for patients, while also reducing the risk of post-operative complications.

The SurgyPad's patent award underscores U.S. Surgitech's commitment to investing in research and development to bring groundbreaking medical solutions to the market. The product has already received widespread recognition from surgeons and healthcare professionals, as well as being added to most of the top Group Purchasing Organization contracts in the U.S. for its potential to revolutionize patient positioning.

"We believe that the SurgyPad has the potential to transform the surgical landscape," added Maaz Meah. "Its all-encompassing design and enhanced safety features make it an indispensable tool for surgeons and nursing staff, helping them achieve better outcomes and improve patient care."

Complimenting the SurgyPad, U.S. Surgitech has also announced its newest product line, SurgyFoam. This new comprehensive product line aims to address the specific challenges faced by surgeons and medical professionals related to patient positioning and nerve protection. The SurgyFoam product line comprises a variety of surgical foam devices, each tailored to specific surgical applications, including (but not limited to) general, robotic, laparoscopic, and orthopedic surgery. As surgeries continue to evolve and the number of robotic procedures increases, patient positioning is becoming increasingly vital within hospital surgery suites.

About U.S. Surgitech:

U.S. Surgitech Inc. is a growing provider of surgical devices and instruments to many healthcare institutions throughout the country, as well as globally. Founded in 2003, U.S. Surgitech has emerged as an industry leader with exceptional customer service. Located in Carol Stream, IL, U.S. Surgitech offers a variety of top-tier surgical products based on the needs of the consumer. With a team of experienced professionals and a commitment to excellence, U.S. Surgitech continues to make significant contributions to the medical industry.

Marketing Department
U.S. Surgitech
+1 800-970-4877
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.